Svk Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 8.75 M
- Company Age 14 Year, 20 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.63 Cr
- Revenue Growth -12.43%
- Profit Growth -24.07%
- Ebitda 1.35%
- Net Worth 14.36%
- Total Assets -12.35%
About Svk Pharma
Svk Pharma Private Limited (SPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 January 2011 and has a history of 14 years. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.75 M.
The company currently has active open charges totaling ₹4.63 Cr.
Krishna Bheemireddy and Chinnakrishna Bhimareddy serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100TG2011PTC072241
-
Company No.
072241
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Jan 2011
-
Date of AGM
16 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Svk Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Bheemireddy
|
Director | 13-Jan-2011 | Current |
|
Chinnakrishna Bhimareddy
|
Director | 13-Jan-2011 | Current |
Financial Performance of Svk Pharma.
Svk Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.43% decrease. The company also saw a substantial fall in profitability, with a 24.07% decrease in profit. The company's net worth Soared by an impressive increase of 14.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Svk Pharma?
In 2023, Svk Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.63 Cr
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 4.63 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Nov 2020 | Axis Bank Limited | ₹4.63 Cr | Open |
How Many Employees Work at Svk Pharma?
Svk Pharma has a workforce of 15 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Svk Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svk Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.